Three-Dimensional Analysis of Binding Sites for Predicting Binding Affinities in Drug Design

J Chem Inf Model. 2019 Nov 25;59(11):4654-4662. doi: 10.1021/acs.jcim.9b00206. Epub 2019 Oct 22.

Abstract

Understanding the interaction between drug molecules and proteins is one of the main challenges in drug design. Several tools have been developed recently to decrease the complexity of the process. Artificial intelligence and machine learning methods offer promising results in predicting the binding affinities. It becomes possible to do accurate predictions by using the known protein-ligand interactions. In this study, the electrostatic potential values extracted from 3-dimensional grid cubes of the drug-protein binding sites are used for predicting binding affinities of related complexes. A new algorithm with a dynamic feature selection method was implemented, which is derived from Compressed Images For Affinity Prediction (CIFAP) study, to predict binding affinities of Checkpoint Kinase 1 and Caspase 3 inhibitors.

MeSH terms

  • Artificial Intelligence
  • Binding Sites
  • Caspase 3 / chemistry
  • Caspase 3 / metabolism
  • Caspase Inhibitors / chemistry
  • Caspase Inhibitors / pharmacology*
  • Checkpoint Kinase 1 / antagonists & inhibitors
  • Checkpoint Kinase 1 / chemistry
  • Checkpoint Kinase 1 / metabolism
  • Drug Design
  • Drug Discovery / methods*
  • Humans
  • Imaging, Three-Dimensional
  • Ligands
  • Machine Learning
  • Molecular Docking Simulation
  • Protein Binding
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology*
  • Static Electricity

Substances

  • Caspase Inhibitors
  • Ligands
  • Protein Kinase Inhibitors
  • Checkpoint Kinase 1
  • Caspase 3